Skip to main content
Log in

A British national lymphoma investigation randomised trial of single agent chlorambucil plus radiotherapyversus radiotherapy alone in low grade, localised non-hodgkins Lymphoma

  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Local radiotherapy (RT) alone was compared with radiotherapy plus continuous oral chlorambucil (RT + CHL) for the treatment of localised, low grade non-Hodgkins lymphoma (NHL) in a prospective randomised study of 148 patients. After a maximum of 18 years follow up there was no significant difference in overall survival or disease free survival between the two treatment groups. Age greater than 50 years and low serum albumin at diagnosis correlated with a poor prognosis in the series overall. Over one third of patients with Iocalised, low grade NHL may be cured by RT alone and adiuvant chlorambucil as initial therapy confers no survival advantage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Phillips D L Radiotherapy in the treatment of localised nonHodgkins lymphomas.Clinical Radiology,32, 543–546 (1981).

    Article  PubMed  CAS  Google Scholar 

  2. Goffinet D R, Warnke R, Dunnick N Ret al. Clinical and surgical (laparotomy) evaltaation of patients with nonHodgkins lymphoma.Cancer Treatment Reports,61, 981–992 (1977).

    PubMed  CAS  Google Scholar 

  3. Chabner B A, Johnson R E and Young R C. Sequential non-surgical and surgical staging of nonHodgkins lymphoma.Ann Intern Med,85, 149–154 (1976).

    PubMed  CAS  Google Scholar 

  4. Lister T A. The management of follicular lymphoma.Annals of Ontology,2 (suppl. 2), 131–135 (1991).

    Google Scholar 

  5. Richards M, Gregory W M, Hall P Aet al. Management of localised nonHodgkins lymphoma: the experience at St. Bartholemews hospital 1972-1985.Haematological Oncology,7, 118 (1989).

    Google Scholar 

  6. McLaughlin P, Fuller L M, Velasquez M Set al. Stage III follicular lymphoma: treatment results for 76 patients.Cancer,58, 1596–1602 (1986).

    Article  PubMed  CAS  Google Scholar 

  7. Newland A C, Linch D C, Vaughan-Hudson G, and Vaughan-Hudson B. Results in the treatment of stage III low grade lymphoma: the BNLI experience. 24thCongress of the International Society of Haematology (London), 14 (abstract) (1992).

  8. Nissen N I, Ersboll J, Hansen H Set al.. A randomised study of radiotherapy versus radiotherapy plus chemotherapy in stage III non-Hodgkins lymphoma.Cancer,52, 17(1983).

    Article  Google Scholar 

  9. Bennett M H, FarrerBrown, H K, and Jelliffe A M. Classification of nonHodgkins lymphomas.Lancet,ii, 405–406 (1974).

    Article  Google Scholar 

  10. Peto R, Pike M C, Armitage P, Breslow N E, Cox D R, Howard S V, Mantel N, McPherson K, Peto J and Smith P. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples.British Journal of Cancer,35, 139 (1977).

    Google Scholar 

  11. Cox D R. Regression models and life tables.Journal of the Royal Statistical Society (series B)34, 187–220 (1972).

    Google Scholar 

  12. Paryani S B, Hoppe R T, Cox R S, Colby T V,et al. Analysis of nonHodgkins lymphomas with nodular and favourable histologies, stage I and II.Cancer,52, 2300–2307 (1983).

    Article  PubMed  CAS  Google Scholar 

  13. McLaughlin P, Fuller L, Redman J, Hagemeister F, Durr E, Atlen P, Holmes L, Velasquez W, Swan F and Cabanillas F. Stage III low grade lymphomas; a prospective trial of combination chemotherapy and radiotherapy.Annals of Oncology,2 (suppl. 2), 137–140 (1991).

    PubMed  Google Scholar 

  14. Chert M G, Prosnitz L R, GonzalezServa A and Fischer D B. Results of radiotherapy in control of stage I and II nonHodgkins lymphoma.Cancer,43, 1245–1254 (1979).

    Article  Google Scholar 

  15. McLaughlin P, Cabanillas F, and Newland A C Controversies in therapy for the low grade lymphomas. In:Haematological Oncology, vol. 1. Eds Newland A C, Armitage J, Burnett A and Keating A. Cambridge University Press (Cambridge UK); pp173–194 (1991).

    Google Scholar 

  16. Gallagher C J and Lister T A. Follicular nonHodgkins lymphoma. In:Ballieres Clinical Haematology, vol 1 (1). Eds McElwain T J, Lister T A. Balliere Tindall (London), pp 141–156 (1987).

    Google Scholar 

  17. Coiffier B. How should prognostic factors influence therapy in follicular lymphomas? Annals of Oncology2, 619–620 (1991).

    PubMed  CAS  Google Scholar 

  18. Leonard R C F, Hayward R L, Prescott R J and Wang J X. The identification of discrete prognostic groups in low grade non-Hodgkins lymphoma.Annals of Oncology,2, 655–662 (1991).

    PubMed  CAS  Google Scholar 

  19. Spinolo J A, Cabanillas F, Dixon D Oet al.. Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure.Annals of Oncology,3, 227–232 (1992).

    PubMed  CAS  Google Scholar 

  20. Rosenberg S A. The low grade non-Hodgkins lymphomas: Challenges and opportunities.J Clin Oncol,3, 299–310 (1985).

    PubMed  CAS  Google Scholar 

  21. Bastion Y, Berger F, Bryon P A, Felman P, Ffrench M and Coiffier B. Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years.Annals of Oncology 2 (Suppl. 2), 123–129 (1991).

    PubMed  Google Scholar 

  22. Aviles A, DiazMaqueo J C, Sanchez E, Cortes H D, and Ayala J R. Long term results in patients with low grade nodular nonHodgkins lymphoma.Acta Oncologica,30, 329–333.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelsey, S.M., Newland, A.C., Hudson, G.V. et al. A British national lymphoma investigation randomised trial of single agent chlorambucil plus radiotherapyversus radiotherapy alone in low grade, localised non-hodgkins Lymphoma. Med Oncol 11, 19–25 (1994). https://doi.org/10.1007/BF02990087

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02990087

Key Words

Navigation